Press Release
« Back
Celldex Therapeutics Announces Upcoming Presentation at the Cowen and Company 35th Annual Health Care Conference
Mar 3, 2015
A live webcast of the presentation will be available online on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay of the presentation will be available through
About
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Visit www.celldex.com.
CONTACT: Celldex Company Contacts: Investors:Source:Sarah Cavanaugh Vice President of Investor Relations& Corp Communications Celldex Therapeutics, Inc. (781) 433-3161 scavanaugh@celldex.com or Media:Dan Budwick Pure Communications, Inc. (973) 271-6085 dan@purecommunicationsinc.com
News Provided by Acquire Media